RFP on Vaccine Impact Optimization
RFP on Vaccine Impact Optimization supports researchers and teams improving existing vaccine use through research and practical work to increase health impact, primarily in low- and middle-income countries.
Funder: Coefficient Giving
Due Dates: December 21, 2026, at 11:59 PM PST (Expression of interest)
Funding Amounts: Up to $30 million total; no maximum set for individual proposals
Summary: Supports research and practical work to improve existing vaccine use and health impact, primarily in low- and middle-income countries.
Key Information: Vaccines must be licensed, WHO-prequalified, or in late-stage development with an established safety profile.
Description
Coefficient Giving’s open call supports research and other work that increases the health impact of existing vaccines, primarily for people in low- and middle-income countries (LMICs). It seeks opportunities to improve protection, extend use to additional populations, and simplify schedules or reduce costs so more people can benefit. Eligible approaches include clinical trials, observational studies, modeling, analysis, and regulatory or policy work.
The call prioritizes substantial and neglected disease burdens, cost-effectiveness, and credible routes from evidence to specific regulatory, program, or policy decisions. Supported work can optimize doses and schedules, test new indications, inform immunization decisions, or remove regulatory, manufacturing, storage, and transport barriers. Both well-developed proposals and promising early-stage project ideas are welcome.
